Andrew Davies et al <br/><br/>
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works